Abbott Dissolving Stent Granted Earlier-Than-Expected FDA Approval

Abbott Dissolving Stent Granted Earlier-Than-Expected FDA Approval

Source: 
Medical Devices and Diagnostics Industry
snippet: 

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic limb-threatening ischemia below the knee and deliver Everolimus to support vessel healing through a stent that dissolves over time.